| 1 | [SID56324721] | Active | Potency | 0.1585 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 0.1585 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 2 | [SID56324721] | Active | Potency | 0.1585 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 0.1585 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 3 | [SID56320652] | Active | Potency | 0.3162 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | Potency | 0.3162 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 4 | [SID56324721] | Active | Potency | 0.5012 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 0.5012 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 5 | [SID56324721] | Active | Potency | 0.5012 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 0.5012 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 6 | [SID56324721] | Active | Potency | 0.7943 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 0.7943 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 7 | [SID56320652] | Active | IC50 | 1.06 | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence resonance energy transfer assay [AID624383, Type: confirmatory] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | IC50 | 1.06 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence resonance energy transfer assay | | AID | 624383 | | BioAssay type | confirmatory | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 8 | [SID56320652] | Active | Potency | 1.122 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | Potency | 1.122 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 9 | [SID56324721] | Active | Potency | 1.2589 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 10 | [SID56324721] | Active | Potency | 1.4125 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 11 | [SID56324721] | Active | AC50 | 1.524 | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 [AID449745, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | AC50 | 1.524 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 | | AID | 449745 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 12 | [SID56324721] | Active | AC50 | 1.524 | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 [AID449745, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | AC50 | 1.524 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 | | AID | 449745 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 13 | [SID56320652] | Active | IC50 | 1.819 | Fluorescence-based biochemical high throughput dose response assay for inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID504742, Type: confirmatory] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | IC50 | 1.819 [uM] | | BioAssay | Fluorescence-based biochemical high throughput dose response assay for inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 504742 | | BioAssay type | confirmatory | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 14 | [SID56320652] | Active | Potency | 2.5902 | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen [AID686980, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | Potency | 2.5902 [uM] | | BioAssay | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen | | AID | 686980 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 15 | [SID56324721] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter [AID463254, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter | | AID | 463254 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 16 | [SID56324721] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter [AID463254, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter | | AID | 463254 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 17 | [SID56320652] | Active | IC50 | 4.09 | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) [AID504729, Type: confirmatory] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | IC50 | 4.09 [uM] | | BioAssay | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 504729 | | BioAssay type | confirmatory | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 18 | [SID56320652] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 19 | [SID56320652] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 20 | [SID56320652] | Active | IC50 | 12.03 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | IC50 | 12.03 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 21 | [SID56320652] | Active | Potency | 79.4328 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID56324721] | Active | IC50 | 83.56 | A Counter Screen to identiry small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium [AID2401, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | IC50 | 83.56 [uM] | | BioAssay | A Counter Screen to identiry small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium | | AID | 2401 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID56320652] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID56320652] | Active | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID56320652] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats [AID652065, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats | | AID | 652065 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID56320652] | Active | | | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex [AID652068, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex | | AID | 652068 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID56324721] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 28 | [SID56320652] | Active | | | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504690, Type: screening] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 504690 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 29 | [SID56324721] | Active | | | RNA aptamer-based HTS for inhibitors of GRK2 [AID488847, Type: screening] | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | RNA aptamer-based HTS for inhibitors of GRK2 | | AID | 488847 | | BioAssay type | screening | | Target | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] | | PubMed | | | Data Table |  |
|
| 30 | [SID56324721] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 31 | [SID56324721] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 32 | [SID56324721] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 33 | [SID56320652] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 34 | [SID56320652] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 35 | [SID56324721] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 36 | [SID56324721] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 37 | [SID56324721] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 38 | [SID56324721] | Active | | | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library [AID2557, Type: screening] | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library | | AID | 2557 | | BioAssay type | screening | | Target | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] | | PubMed | | | Data Table |  |
|
| 39 | [SID56324721] | Active | | | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library [AID2557, Type: screening] | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library | | AID | 2557 | | BioAssay type | screening | | Target | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] | | PubMed | | | Data Table |  |
|
| 40 | [SID56320652] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 41 | [SID56320652] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 42 | [SID56320652] | Active | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 43 | [SID56320652] | Active | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 44 | [SID56324721] | Active | | | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID489030, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56324721 | | CID | 16218503 | | Outcome | Active | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 489030 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 45 | [SID56320652] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 46 | [SID56320652] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 47 | [SID56320652] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 48 | [SID56320652] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 49 | [SID56320652] | Active | | | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay [AID493098, Type: screening] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay | | AID | 493098 | | BioAssay type | screening | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 50 | [SID56320652] | Active | | | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay [AID493098, Type: screening] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56320652 | | CID | 16218503 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay | | AID | 493098 | | BioAssay type | screening | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|